Trademarkia Logo

Australia

AU$
Trademark Search
AMUNIX

View On IPO.GOV.AU

AMUNIX
Registered: Registered/protected

Last updated on 17 Jun 2022

Owner Info

Amunix Pharmaceuticals, Inc.

2 Tower Pl, #1100

South San Francisco, California, 94080 UNITED STATES OF AMERICA,

Serial Number

2226449 filed on 8 Nov 2021

Correspondent

WRAYS PTY LTD

L 20,

600 Bourke St,

Melbourne, VIC, 3000 AUSTRALIA

AMUNIX

Classification Information

Class [001]
Chemical preparations for use in the manufacture of pharmaceuticals; chemical products for use in pharmaceuticals; chemical preparations for use in th Read More

Class [005]
Pharmaceutical preparations; pharmaceutical products; pharmaceutical products for use by humans; pharmaceutical preparations for the treatment of canc Read More

Class [010]
Medical and pharmaceutical apparatus and instruments; apparatus for use in the administration and delivery of drugs; drug delivery devices; injector Read More

Class [041]
Education services; educational advisory services; medical education services; pharmaceutical education services; medical and pharmaceutical tuition Read More

Class [042]
Pharmaceutical research services; pharmaceutical development; research relating to pharmaceuticals; chemical research; medical research; scientific re Read More

Class [044]
Advisory services relating to pharmaceutical products; pharmaceutical advisory services; provision of pharmaceutical information; providing informatio Read More

Mark Details

Serial Number

2226449

Registered On

8 Nov 2021

Renewal On

8 Nov 2031

Mark Type

WORD

Legal History

Show more

Status DateAction Taken
17th Jun 2022IP Right Registered correspondence sent
17th Jun 2022IP Right Registration Published
17th Jun 2022Status change to Registered/Protected
9th Apr 2022Application Accepted correspondence sent
9th Apr 2022IP Right has been Examined
9th Apr 2022IP Right Acceptance Published
19th Jan 2022Early Acceptance Notice correspondence sent
19th Jan 2022Status change to Accepted
10th Nov 2021Awaiting examination
8th Nov 2021IP Right Filed correspondence sent